Velimir Luketic is a Gastroenterology physician affiliated with Virginia Commonwealth University. OpenAlex indexes 279 publications with 25,299 citations (h-index 76); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1250 E Marshall St
Richmond, VA 232985051
Telephone
828-406-0804Registry record last updated 11 Sept 2025.
Clinical trials
- LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Sponsor: Veloxis Pharmaceuticals
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ipsen Pharma SASProgram year20241 payment
- Ipsen Biopharmaceuticals, IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
93.3%Bile Acid72.2%Ursodiol100%Part D≥31 patientsBile acids and derivatives21.1%Ocaliva100%Part D<11 patientsAnti-infectives
6.7%Nucleoside and nucleotide reverse transcriptase inhibitors6.7%Vemlidy100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1992–2010 per NIH RePORTER. The latest:
- NATURAL HISTORY OF PRIMARY BILIARY CIRRHOSIS AFTER TREATMENT WITH METHOTREXATE
Virginia Commonwealth University
FY2010$23,677M01RR000065 - HIGH DOSE UDCA FOR PRIMARY SCLEROSING CHOLANGITIS
Virginia Commonwealth University
FY2010$3,866M01RR000065 - STUDIES OF PRIMARY SCLEROSING CHOLANGITIS (STOPSC)
Virginia Commonwealth University
FY2010$806M01RR000065
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
Clinical Gastroenterology and Hepatology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Jasmohan Bajaj, MD
Virginia Commonwealth University
Patrick Ching, MD, MPH
Virginia Commonwealth University
Robert Delorenzo, MD
Virginia Commonwealth University
Michael Kontos, MD
Virginia Commonwealth University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”